Promising experimental drug could shield nerve cells from amyotrophic lateral sclerosis damage

Article excerpt

Amyotrophic lateral sclerosis (ALS) received widespread attention in the summer of 2014 thanks to the Ice Bucket Challenge. Millions of people participated, drenching themselves in ice-cold water to raise awareness of this devastating neurodegenerative disease and generate charitable donations for research. The challenge takes place every year, but ALS still has no known treatment or cure.